Publication | Open Access
MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome
105
Citations
33
References
2015
Year
MDGA2 is a critical tumour suppressor in gastric carcinogenesis; its hypermethylation is an independent prognostic factor in patients with gastric cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1